BioSig Technologies, Inc. (NASDAQ:BSGM – Get Free Report) saw a large decline in short interest in the month of May. As of May 31st, there was short interest totalling 223,800 shares, a decline of 51.5% from the May 15th total of 461,700 shares. Approximately 2.0% of the shares of the company are short sold. Based on an average daily volume of 985,800 shares, the days-to-cover ratio is presently 0.2 days.
Institutional Inflows and Outflows
An institutional investor recently bought a new position in BioSig Technologies stock. Armistice Capital LLC bought a new position in BioSig Technologies, Inc. (NASDAQ:BSGM – Free Report) during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor bought 5,600,000 shares of the company’s stock, valued at approximately $2,660,000. Armistice Capital LLC owned about 62.36% of BioSig Technologies as of its most recent SEC filing. 7.16% of the stock is currently owned by hedge funds and other institutional investors.
BioSig Technologies Stock Up 13.9 %
NASDAQ BSGM traded up $0.05 during trading hours on Friday, hitting $0.45. The company had a trading volume of 191,948 shares, compared to its average volume of 449,832. BioSig Technologies has a 52 week low of $0.20 and a 52 week high of $15.50. The firm has a 50 day simple moving average of $1.54 and a 200 day simple moving average of $1.84.
BioSig Technologies Company Profile
BioSig Technologies, Inc, together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures.
Featured Articles
- Five stocks we like better than BioSig Technologies
- What Investors Need to Know About Upcoming IPOs
- MarketBeat Week in Review – 6/10 – 6/14
- Investing in the High PE Growth Stocks
- Top 5 High-Performance Cryptocurrency ETFs to Watch
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- 3 Stocks That Plummeted After the Post-Fed Speech Crash
Receive News & Ratings for BioSig Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioSig Technologies and related companies with MarketBeat.com's FREE daily email newsletter.